- Home
- HNST vs CLLS Comparison
HNST vs CLLS Comparison
Compare HNST & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HNST | CLLS |
|---|---|---|
| Founded | 2012 | 1999 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 375.4M | 394.4M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | HNST | CLLS |
|---|---|---|
| Price | $3.67 | $3.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $3.05 | ★ $8.33 |
| AVG Volume (30 Days) | ★ 1.4M | 31.6K |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | N/A |
| Revenue | ★ $371,317,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.93 | $0.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.07 | $1.36 |
| 52 Week High | $5.28 | $5.48 |
Technical Indicators
Market Signals| Indicator | HNST | CLLS |
|---|---|---|
| Relative Strength Index (RSI) | 61.08 | 38.65 |
| Support Level | $3.15 | $2.94 |
| Resistance Level | $3.71 | $3.38 |
| Average True Range (ATR) | 0.16 | 0.15 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 92.23 | 27.70 |
Price Performance
Historical ComparisonAbout HNST The Honest Company Inc.
The Honest Co Inc is a personal care company dedicated to creating cleanly-formulated and sustainably-designed products for everyone from babies to adults. By combining thoughtful design with science-based innovation, the company delivers personal care products for everyone from babies to adults, spanning categories across wipes, personal care, diapers, and beauty. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.